| AML | Acute myeloid leukemia |
| BM | Bone marrow |
| CDK1 | Cyclin-dependent kinase 1 |
| CP | Chronic pancreatitis |
| CSC | Cancer stem cell |
| CSP | Cancer-specific plectin |
| CTC | Circulating tumor cell |
| CycB | Cyclin B |
| DAMPs | Damage-associated molecular patterns |
| Dlc1 | Deleted in liver cancer 1 |
| EMT | Epithelial–mesenchymal transition |
| EPLIN | Epithelial protein lost in neoplasm |
| ESCC | Esophageal squamous cell carcinoma |
| EUS-FNA | Endoscopic ultrasound-guided fine-needle aspiration |
| ExAC | Exosome Aggregation Consortium |
| FUS | Fused in sarcoma |
| GEO | Gene Expression Omnibus |
| GNP | Gold nanoparticle |
| GTEx | Genotype-Tissue Expression |
| HR | Hazard ratio |
| HMGB-1 | High mobility group box protein 1 |
| HNSCC | Head and neck squamous cell carcinoma |
| IF | Intermediate filament |
| IHC | Immunohistochemistry |
| IPMNs | Intraductal papillary mucinous neoplasms |
| miR | microRNA |
| MRI | Magnetic resonance imaging |
| MT | Microtubule |
| NP | Nanoparticle |
| OC | Ovarian Cancer |
| OSCC | Oral squamous cell carcinoma |
| PanIN | Pancreatic intraepithelial neoplasia |
| PDAC | Pancreatic ductal adenocarcinoma |
| PKC | Protein kinase C |
| PTP | Plectin-targeting peptide |
| RACK1 | Receptor of activated protein C kinase 1 |
| RON | Recepteur d’origine nantais |
| ROS | Reactive oxygen species |
| SCC | Squamous cell carcinoma |
| SPECT | Single-photon emission/CT |
| TARGET | Therapeutically Applicable Research to Generate Effective Treatments |
| TCGA | The Cancer Genome Atlas |
| TGCT | Testicular germ cell tumor |
| TMA | Tissue microarray |
| TNF | Tumor necrosis factor |